Suppressive effect of azithromycin on Plasmodium berghei mosquito stage development and apicoplast replication

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Shimizu, Shoichi ^a   Osada, Yoshio ^a   Kanazawa, Tamotsu ^a   Tanaka, Yoshiya ^a   Arai, Meiji ^b  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; ANTIMALARIAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOPHELES STEPHENSI; ANTIMALARIAL ACTIVITY; APICOPLAST; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; FEMALE; GAMETOCYTE; MALARIA; MALARIA CONTROL; MIDGUT; MOSQUITO; MOUSE; NONHUMAN; OOCYST; PARASITE DEVELOPMENT; PARASITE TRANSMISSION; PARASITEMIA; PLASMODIUM (LIFE CYCLE STAGE); PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; SPOROZOITE; TREATMENT OUTCOME; ANIMAL; ANOPHELES; BAGG ALBINO MOUSE; DISEASE MODEL; GAMETOGENESIS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; LIFE CYCLE; PARASITOLOGY; PHYSIOLOGY; PLASTID; POLYMERASE CHAIN REACTION;

ANIMALS; ANOPHELES; ANTIMALARIALS; AZITHROMYCIN; DISEASE MODELS, ANIMAL; GAMETOGENESIS; HUMANS; LIFE CYCLE STAGES; MICE; MICE, INBRED BALB C; OOCYSTS; PLASMODIUM BERGHEI; PLASTIDS; POLYMERASE CHAIN REACTION; SPOROZOITES;

EID: 77949444264     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-73     Document Type: Article

References (50)

1. M Aregawi R Cibulskis M Otten R Williams C Dye, World Malaria Report 2008 World Health Organization, Geneva 2008
2. Malaria transmission-blocking vaccines - how can their development be supported? R Carter KN Mendis LH Miller L Molineaux A Saul, Nat Med 2000 6 241 244 10.1038/73062 10700212 (Pubitemid 30148601)
3. Transmission-blocking vaccines: Uses and current status of development. DC Kaslow, Int J Parasitol 1997 27 183 189 10.1016/S0020-7519(96)00148-8 9088989 (Pubitemid 27139709)
4. Antimalarial drugs and the mosquito transmission of Plasmodium. GA Bucher, Int J Parasitol 1997 27 975 987 10.1016/S0020-7519(97)00079-9 9363480
5. Prevention of sporogony of Plasmodium falciparum and P. berghei in Anopheles stephensi mosquitoes by transmission-blocking antimalarials. RE Coleman AK Nath I Schneider GH Song TA Klein WK Milhous, Am J Trop Med Hyg 1994 50 646 653 8203716 (Pubitemid 24196356)
6. Community perceptions of a mass administration of an antimalarial drug combination in The Gambia. S De Martin L von Seidlein JL Deen M Pinder G Walraven BM Greenwood, Trop Med Int Health 2001 6 442 448 10.1046/j.1365-3156. 2001.00723.x 11422958 (Pubitemid 32525662)
7. Mass drug administration of antimalarial drugs. L von Seidlein BM Greenwood, Trends Parasitol 2003 10 452 460 10.1016/j.pt.2003.08.003 (Pubitemid 38366142)
8. The role of anti-malarial drugs in eliminating malaria. NJ White, Malar J 2008 7 Suppl 1 8 10.1186/1475-2875-7-S1-S8 19091042
9. Chemotherapeutic malaria control operation by single dose or Fansidar plus primaquine in North Sumatra, Indonesia. H Doi A Kaneko W Panjaitan A Ishii, Southeast Asian J Trop Med Public Health 1989 20 341 349 2633346
10. Malaria eradication on islands. A Kaneko G Taleo M Kalkoa S Yamar T Kobayakawa A Björkman, Lancet 2000 356 1560 1564 10.1016/S0140-6736(00) 03127-5 11075770
11. Transmission-blocking activities of quinine, primaquine, and artesunate. K Chotivanich J Sattabongkot R Udomsangpetch S Looareesuwan NPJ Day RE Coleman NJ White, Antimicrob Agents Chemother 2006 50 1927 1930 10.1128/AAC.01472-05 16723547 (Pubitemid 43807507)
12. Prevention of sporogony of Plasmodium vivax in Anopheles dirus mosquitoes by transmission-blocking antimalarials. RE Coleman N Polsa N Eikarat TM Kollars Jr J Sattabongkot, Am J Trop Med Hyg 2001 65 214 218 11561707 (Pubitemid 32847814)
13. Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria. S Pukrittayakamee K Chotivanich A Chantra R Clemens S Looareesuwan NJ White, Antimicrob Agents Chemother 2004 48 1329 1334 10.1128/AAC.48.4.1329-1334.2004 15047537 (Pubitemid 38405489)
14. Isonicotinic acid hydrazide: an anti-tuberculosis drug inhibits malarial transmission in the mosquito gut. M Arai YIH Alavi J Mendoza O Billker RE Sinden, Exp Parasitol 2004 106 30 36 10.1016/j.exppara.2004.01.002 15013786 (Pubitemid 38317196)
15. In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin. AB Sidhu Q Sun LJ Nkrumah MW Dunne JC Sacchettini DA Fidock, J Biol Chem 2007 282 2494 2504 10.1074/jbc.M608615200 17110371 (Pubitemid 47076745)
16. Pregnancy outcome following gestational exposure to azithromycin. M Sarkar C Woodland G Koren AR Einarson, BMC Pregnancy Childbirth 2006 6 18 10.1186/1471-2393-6-18 16734900 (Pubitemid 43950611)
17. Paediatric safety of azithromycin: worldwide experience. G Treadway D Pontani, J Antimicrob Chemother 1996 37 Suppl C 143 149 8818855 (Pubitemid 26283389)
18. Efficacy of azithromycin as a causal prophylactic agent against murine malaria. SL Andersen AL Ager P McGreevy BG Schuster W Ellis J Berman, Antimicrob Agents Chemother 1994 38 1862 1863 7986022 (Pubitemid 24250739)
19. Antimalarial activity of azithromycin and erythromycin against Plasmodium berghei. BA Gingras JB Jensen, Am J Trop Med Hyg 1993 49 101 105 8394660
20. In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. H Noedl S Krudsood W Leowattana N Tangpukdee W Thanachartwet S Looareesuwan RS Miller M Fukuda K Jongsakul K Yingyuen S Sriwichai C Ohrt C Knirsch, Antimicrob Agents Chemother 2007 51 651 656 10.1128/AAC.01023-06 17116669 (Pubitemid 46185286)
21. Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy. RM Chico R Pittrof B Greenwood D Chandramohan, Malar J 2008 7 255 10.1186/1475-2875-7-255 19087267
22. Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. H Noedl S Krudsood K Chalermratana U Silachamroon W Leowattana N Tangpukdee S Looareesuwan RS Miller M Fukuda K Jongsakul S Sriwichai J Rowan H Bhattacharyya C Ohrt C Knirsch, Clin Infect Dis 2006 43 1264 1271 10.1086/508175 17051490
23. A double-blind, randomized study of azithromycin compared to chloroquine for the treatment of Plasmodium vivax malaria in India. MW Dunne N Singh M Shukla N Valecha PC Bhattacharyya K Patel MK Mohapatra J Lakhani CU Devi T Adak V Dev RS Yadav C Lele K Patki, Am J Trop Med Hyg 2005 73 1108 1111 16354821 (Pubitemid 43038263)
24. Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast. EL Dahl PJ Rosenthal, Antimicrob Agents Chemother 2007 51 3485 3490 10.1128/AAC.00527-07 17698630
25. Methods in Anopheles Research Manual. http://www.mr4.org/ AnophelesProgram/tabid/553/Default.aspx
26. A central role for P48/45 in malaria parasite male gamete fertility. MR van Dijk CJ Janse J Thompson AP Waters JA Braks HJ Dodemont HG Stunnenberg GJ van Gemert RW Sauerwein W Eling, Cell 2001 104 153 164 10.1016/S0092-8674(01) 00199-4 11163248 (Pubitemid 32144980)
27. Gametocytogenesis: the puberty of Plasmodium falciparum. AM Talman O Domarle FE McKenzie F Ariey V Robert, Malar J 2004 3 24 10.1186/1475-2875-3-24 15253774 (Pubitemid 39319749)
28. Both mosquito-derived xanthurenic acid and a host blood-derived factor regulate gametogenesis of Plasmodium in the midgut of the mosquito. M Arai O Billker HR Morris M Panico M Delcroix D Dixon SV Ley RE Sinden, Mol Biochem Parasitol 2001 116 17 24 10.1016/S0166-6851(01)00299-7 11463462 (Pubitemid 32706423)
29. Mitochondrial evolution and functions in malaria parasites. AB Vaidya MW Mather, Annu Rev Microbiol 2009 63 249 267 10.1146/annurev.micro.091208.073424 19575561
30. Primer-BLAST. http://www.ncbi.nlm.nih.gov/tools/primer-blast/
31. Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum. TN Ramya S Mishra K Karmodiya N Surolia A Surolia, Antimicrob Agents Chemother 2007 51 307 316 10.1128/AAC.00808-06 17060533 (Pubitemid 46047720)
32. 15-deoxyspergualin primarily targets the trafficking of apicoplast proteins in Plasmodium falciparum. TN Ramya K Karmodiya A Surolia N Surolia, J Biol Chem 2007 282 6388 6397 10.1074/jbc.M610251200 17194705 (Pubitemid 47100825)
33. GFP-targeting allows visualization of the apicoplast throughout the life cycle of live malaria parasites. RR Stanway T Witt B Zobiak M Aepfelbacher VT Heussler, Biol Cell 2009 101 415 430 10.1042/BC20080202 19143588
34. A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. MW Dunne N Singh M Shukla N Valecha PC Bhattacharyya V Dev K Patel MK Mohapatra J Lakhani R Benner C Lele K Patki, J Infect Dis 2005 191 1582 1588 10.1086/429343 15838784 (Pubitemid 40656745)
35. Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose-ranging study. RS Miller C Wongsrichanalai N Buathong P McDaniel DS Walsh C Knirsch C Ohrt, Am J Trop Med Hyg 2006 74 401 406 16525097 (Pubitemid 46774360)
36. Maternal inheritance of extrachromosomal DNA in malaria parasites. A Creasey K Mendis J Carlton D Williamson I Wilson R Carter, Mol Biochem Parasitol 1994 65 95 98 10.1016/0166-6851(94)90118-X 7935632 (Pubitemid 24232819)
37. Apicoplast and mitochondrion in gametocytogenesis of Plasmodium falciparum. N Okamoto TP Spurck CD Goodman GI McFadden, Eukaryot Cell 2009 8 128 132 10.1128/EC.00267-08 18996983
38. Development of the endoplasmic reticulum, mitochondrion and apicoplast during the asexual life cycle of Plasmodium falciparum. GG van Dooren M Marti CJ Tonkin LM Stimmler AF Cowman GI McFadden, Mol Microbiol 2006 57 405 419 10.1111/j.1365-2958.2005.04699.x (Pubitemid 40979342)
39. Life cycles and morphology. I Landau Y Boulard, Rodent Malaria New York: Academic Press, Killick-Kenckrick R, Peters W, 1978 53 84
40. Progression of Plasmodium berghei through Anopheles stephensi is density-dependent. RE Sinden EJ Dawes Y Alavi J Waldock O Finney J Mendoza GA Butcher L Andrews AV Hill SC Gilbert MG Basanez, PLoS Pathog 2007 3 195 10.1371/journal.ppat.0030195 18166078
41. Effects of different antimalarial drugs on gametocyte carriage in P. vivax malaria. S Pukrittayakamee M Imwong P Singhasivanon K Stepniewska NJ Day NJ White, Am J Trop Med Hyg 2008 79 378 384 18784229
42. Azithromycin in the treatment of Plasmodium falciparum gametocytes: a preliminary observation. BE Rino TT Van F Giovanni M Franco, J Trop Pediatr 2000 46 56 10.1093/tropej/46.1.56 10730047 (Pubitemid 30099154)
43. Heterogeneity in patterns of malarial oocyst infections in the mosquito vector. GF Medley RE Sinden S Fleck PF Billingsley N Tirawanchai MH Rodriguez, Parasitology 1993 106 441 449 10.1017/S0031182000076721 8341579 (Pubitemid 23169804)
44. Comparison of direct and membrane feeding methods to infect Anopheles arabiensis with Plasmodium falciparum. HP Awono-Ambene L Diawara V Robert, Am J Trop Med Hyg J 2001 64 32 34 (Pubitemid 32550095)
45. Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission. AL Ouédraogo T Bousema P Schneider SJ de Vlas E Ilboudo-Sanogo N Cuzin-Ouattara I Nébié W Roeffen JP Verhave AJ Luty R Sauerwein, PLoS One 2009 4 8410 10.1371/journal.pone.0008410 20027314
46. Population dynamics of sporogony for Plasmodium vivax parasites from western Thailand developing within three species of colonized Anopheles mosquitoes. GE Zollner N Ponsa GW Garman S Poudel JA Bell J Sattabongkot RE Coleman JA Vaughan, Malar J 2006 5 68 10.1186/1475-2875-5-68 16887043 (Pubitemid 44337015)
47. Clinical applications of azithromycin microspheres in respiratory tract infections. F Blasi S Aliberti P Tarsia, Int J Nanomedicine 2007 2 551 559 18203423
48. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. AE Girard D Girard AR English TD Gootz CR Cimochowski JA Faiella SL Haskell JA Retsema, Antimicrob Agents Chemother 1987 31 1948 1954 2830841
49. Safety, toleration, and pharmacokinetics of intravenous azithromycin. DR Luke G Foulds SF Cohen B Levy, Antimicrob Agents Chemother 1996 40 2577 2581 8913468 (Pubitemid 26367647)
50. Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models. D Girard SM Finegan MW Dunne ME Lame, J Antimicrob Chemother 2005 56 365 371 10.1093/jac/dki241 16002421 (Pubitemid 41158527)